This report contains market size and forecasts of Respiratory Diseases Diagnostic Testing in Global, including the following market information:
Global Respiratory Diseases Diagnostic Testing Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Respiratory Diseases Diagnostic Testing market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Respiratory Diseases Diagnostic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Diseases Diagnostic Testing Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Respiratory Diseases Diagnostic Testing Market Segment Percentages, By Type, 2020 (%)
Imaging Test
Respiratory Measurement
Blood Gas Test
Other
China Respiratory Diseases Diagnostic Testing Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Respiratory Diseases Diagnostic Testing Market Segment Percentages, By Application, 2020 (%)
Hospitals
Physician Clinics
Clinical Laboratories
Others
Global Respiratory Diseases Diagnostic Testing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Respiratory Diseases Diagnostic Testing Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Respiratory Diseases Diagnostic Testing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Respiratory Diseases Diagnostic Testing Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Philips Healthcare
BD
Abbott
Thermo Fisher Scientific
Roche
ResMed
Fischer & Paykel
Medtronic
MGC Diagnostics
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Respiratory Diseases Diagnostic Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Respiratory Diseases Diagnostic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Respiratory Diseases Diagnostic Testing Overall Market Size
2.1 Global Respiratory Diseases Diagnostic Testing Market Size: 2021 VS 2027
2.2 Global Respiratory Diseases Diagnostic Testing Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Respiratory Diseases Diagnostic Testing Players in Global Market
3.2 Top Global Respiratory Diseases Diagnostic Testing Companies Ranked by Revenue
3.3 Global Respiratory Diseases Diagnostic Testing Revenue by Companies
3.4 Top 3 and Top 5 Respiratory Diseases Diagnostic Testing Companies in Global Market, by Revenue in 2020
3.5 Global Companies Respiratory Diseases Diagnostic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Respiratory Diseases Diagnostic Testing Players in Global Market
3.6.1 List of Global Tier 1 Respiratory Diseases Diagnostic Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Respiratory Diseases Diagnostic Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Respiratory Diseases Diagnostic Testing Market Size Markets, 2021 & 2027
4.1.2 Imaging Test
4.1.3 Respiratory Measurement
4.1.4 Blood Gas Test
4.1.5 Other
4.2 By Type - Global Respiratory Diseases Diagnostic Testing Revenue & Forecasts
4.2.1 By Type - Global Respiratory Diseases Diagnostic Testing Revenue, 2016-2021
4.2.2 By Type - Global Respiratory Diseases Diagnostic Testing Revenue, 2022-2027
4.2.3 By Type - Global Respiratory Diseases Diagnostic Testing Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Respiratory Diseases Diagnostic Testing Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Physician Clinics
5.1.4 Clinical Laboratories
5.1.5 Others
5.2 By Application - Global Respiratory Diseases Diagnostic Testing Revenue & Forecasts
5.2.1 By Application - Global Respiratory Diseases Diagnostic Testing Revenue, 2016-2021
5.2.2 By Application - Global Respiratory Diseases Diagnostic Testing Revenue, 2022-2027
5.2.3 By Application - Global Respiratory Diseases Diagnostic Testing Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Respiratory Diseases Diagnostic Testing Market Size, 2021 & 2027
6.2 By Region - Global Respiratory Diseases Diagnostic Testing Revenue & Forecasts
6.2.1 By Region - Global Respiratory Diseases Diagnostic Testing Revenue, 2016-2021
6.2.2 By Region - Global Respiratory Diseases Diagnostic Testing Revenue, 2022-2027
6.2.3 By Region - Global Respiratory Diseases Diagnostic Testing Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Respiratory Diseases Diagnostic Testing Revenue, 2016-2027
6.3.2 US Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.3.3 Canada Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.3.4 Mexico Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Respiratory Diseases Diagnostic Testing Revenue, 2016-2027
6.4.2 Germany Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.4.3 France Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.4.4 U.K. Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.4.5 Italy Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.4.6 Russia Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.4.7 Nordic Countries Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.4.8 Benelux Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Respiratory Diseases Diagnostic Testing Revenue, 2016-2027
6.5.2 China Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.5.3 Japan Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.5.4 South Korea Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.5.5 Southeast Asia Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.5.6 India Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Respiratory Diseases Diagnostic Testing Revenue, 2016-2027
6.6.2 Brazil Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.6.3 Argentina Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Respiratory Diseases Diagnostic Testing Revenue, 2016-2027
6.7.2 Turkey Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.7.3 Israel Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.7.4 Saudi Arabia Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
6.7.5 UAE Respiratory Diseases Diagnostic Testing Market Size, 2016-2027
7 Players Profiles
7.1 Philips Healthcare
7.1.1 Philips Healthcare Corporate Summary
7.1.2 Philips Healthcare Business Overview
7.1.3 Philips Healthcare Respiratory Diseases Diagnostic Testing Major Product Offerings
7.1.4 Philips Healthcare Respiratory Diseases Diagnostic Testing Revenue in Global (2016-2021)
7.1.5 Philips Healthcare Key News
7.2 BD
7.2.1 BD Corporate Summary
7.2.2 BD Business Overview
7.2.3 BD Respiratory Diseases Diagnostic Testing Major Product Offerings
7.2.4 BD Respiratory Diseases Diagnostic Testing Revenue in Global (2016-2021)
7.2.5 BD Key News
7.3 Abbott
7.3.1 Abbott Corporate Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Respiratory Diseases Diagnostic Testing Major Product Offerings
7.3.4 Abbott Respiratory Diseases Diagnostic Testing Revenue in Global (2016-2021)
7.3.5 Abbott Key News
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Corporate Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Major Product Offerings
7.4.4 Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Revenue in Global (2016-2021)
7.4.5 Thermo Fisher Scientific Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Respiratory Diseases Diagnostic Testing Major Product Offerings
7.5.4 Roche Respiratory Diseases Diagnostic Testing Revenue in Global (2016-2021)
7.5.5 Roche Key News
7.6 ResMed
7.6.1 ResMed Corporate Summary
7.6.2 ResMed Business Overview
7.6.3 ResMed Respiratory Diseases Diagnostic Testing Major Product Offerings
7.6.4 ResMed Respiratory Diseases Diagnostic Testing Revenue in Global (2016-2021)
7.6.5 ResMed Key News
7.7 Fischer & Paykel
7.7.1 Fischer & Paykel Corporate Summary
7.7.2 Fischer & Paykel Business Overview
7.7.3 Fischer & Paykel Respiratory Diseases Diagnostic Testing Major Product Offerings
7.4.4 Fischer & Paykel Respiratory Diseases Diagnostic Testing Revenue in Global (2016-2021)
7.7.5 Fischer & Paykel Key News
7.8 Medtronic
7.8.1 Medtronic Corporate Summary
7.8.2 Medtronic Business Overview
7.8.3 Medtronic Respiratory Diseases Diagnostic Testing Major Product Offerings
7.8.4 Medtronic Respiratory Diseases Diagnostic Testing Revenue in Global (2016-2021)
7.8.5 Medtronic Key News
7.9 MGC Diagnostics
7.9.1 MGC Diagnostics Corporate Summary
7.9.2 MGC Diagnostics Business Overview
7.9.3 MGC Diagnostics Respiratory Diseases Diagnostic Testing Major Product Offerings
7.9.4 MGC Diagnostics Respiratory Diseases Diagnostic Testing Revenue in Global (2016-2021)
7.9.5 MGC Diagnostics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Respiratory Diseases Diagnostic Testing Market Opportunities & Trends in Global Market
Table 2. Respiratory Diseases Diagnostic Testing Market Drivers in Global Market
Table 3. Respiratory Diseases Diagnostic Testing Market Restraints in Global Market
Table 4. Key Players of Respiratory Diseases Diagnostic Testing in Global Market
Table 5. Top Respiratory Diseases Diagnostic Testing Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Respiratory Diseases Diagnostic Testing Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Respiratory Diseases Diagnostic Testing Revenue Share by Companies, 2016-2021
Table 8. Global Companies Respiratory Diseases Diagnostic Testing Product Type
Table 9. List of Global Tier 1 Respiratory Diseases Diagnostic Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Respiratory Diseases Diagnostic Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Respiratory Diseases Diagnostic Testing Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Respiratory Diseases Diagnostic Testing Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Respiratory Diseases Diagnostic Testing Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Respiratory Diseases Diagnostic Testing Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Respiratory Diseases Diagnostic Testing Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Respiratory Diseases Diagnostic Testing Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2022-2027
Table 30. Philips Healthcare Corporate Summary
Table 31. Philips Healthcare Respiratory Diseases Diagnostic Testing Product Offerings
Table 32. Philips Healthcare Respiratory Diseases Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 33. BD Corporate Summary
Table 34. BD Respiratory Diseases Diagnostic Testing Product Offerings
Table 35. BD Respiratory Diseases Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 36. Abbott Corporate Summary
Table 37. Abbott Respiratory Diseases Diagnostic Testing Product Offerings
Table 38. Abbott Respiratory Diseases Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 39. Thermo Fisher Scientific Corporate Summary
Table 40. Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Product Offerings
Table 41. Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 42. Roche Corporate Summary
Table 43. Roche Respiratory Diseases Diagnostic Testing Product Offerings
Table 44. Roche Respiratory Diseases Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 45. ResMed Corporate Summary
Table 46. ResMed Respiratory Diseases Diagnostic Testing Product Offerings
Table 47. ResMed Respiratory Diseases Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 48. Fischer & Paykel Corporate Summary
Table 49. Fischer & Paykel Respiratory Diseases Diagnostic Testing Product Offerings
Table 50. Fischer & Paykel Respiratory Diseases Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 51. Medtronic Corporate Summary
Table 52. Medtronic Respiratory Diseases Diagnostic Testing Product Offerings
Table 53. Medtronic Respiratory Diseases Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 54. MGC Diagnostics Corporate Summary
Table 55. MGC Diagnostics Respiratory Diseases Diagnostic Testing Product Offerings
Table 56. MGC Diagnostics Respiratory Diseases Diagnostic Testing Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Respiratory Diseases Diagnostic Testing Segment by Type
Figure 2. Respiratory Diseases Diagnostic Testing Segment by Application
Figure 3. Global Respiratory Diseases Diagnostic Testing Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Respiratory Diseases Diagnostic Testing Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Respiratory Diseases Diagnostic Testing Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Respiratory Diseases Diagnostic Testing Revenue in 2020
Figure 8. By Type - Global Respiratory Diseases Diagnostic Testing Revenue Market Share, 2016-2027
Figure 9. By Application - Global Respiratory Diseases Diagnostic Testing Revenue Market Share, 2016-2027
Figure 10. By Region - Global Respiratory Diseases Diagnostic Testing Revenue Market Share, 2016-2027
Figure 11. By Country - North America Respiratory Diseases Diagnostic Testing Revenue Market Share, 2016-2027
Figure 12. US Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Respiratory Diseases Diagnostic Testing Revenue Market Share, 2016-2027
Figure 16. Germany Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 17. France Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Respiratory Diseases Diagnostic Testing Revenue Market Share, 2016-2027
Figure 24. China Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 28. India Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Respiratory Diseases Diagnostic Testing Revenue Market Share, 2016-2027
Figure 30. Brazil Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Respiratory Diseases Diagnostic Testing Revenue Market Share, 2016-2027
Figure 33. Turkey Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Respiratory Diseases Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 37. Philips Healthcare Respiratory Diseases Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. BD Respiratory Diseases Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Abbott Respiratory Diseases Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Roche Respiratory Diseases Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. ResMed Respiratory Diseases Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Fischer & Paykel Respiratory Diseases Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Medtronic Respiratory Diseases Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. MGC Diagnostics Respiratory Diseases Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Philips Healthcare
BD
Abbott
Thermo Fisher Scientific
Roche
ResMed
Fischer & Paykel
Medtronic
MGC Diagnostics